AK-30-NGF

N/A

Report date: 2024/12/18 10:01:40

Base Information

Drug NameAK-30-NGF

Drug Alias NameAK-30-CD4OX-26-NGF

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)Biologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody

Mechanisms of ActionNerve growth factor receptors agonists

TargetsNerve growth factor receptors

Therapy Area/IndicationsAlzheimer Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAlkermes

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesAlkermes

Active IndicationsN/A

Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A